- Senarai Premis Latihan Bagi Pegawai Farmasi Provisional (PRP)
- Protokol Perkhidmatan Farmasi Wad Obstetrik & Ginekologi
- Protokol Thalassaemia Medication Therapy Adherence Clinic (TMTAC)
- Garis Panduan Kaunseling Ubat-ubatan Edisi Keempat (2025)
- Pelan Induk Insiatif Pelupusan Ubat-ubatan Dalam Simpanan Pesakit Demi Kelestarian Alam Sekitar (MyMediSAFE) Edisi 2025
Anda di sini
Formulari Ubat KKM (FUKKM)
| # | Generic Name | MDC | Category | Indications | Pres. Restrictions | Dosage |
|---|---|---|---|---|---|---|
| 301 | Celecoxib 200 mg Capsule | M01AH01-000-C10-01-XXX | A/KK | i) Osteoarthritis ii) Rheumatoid Arthritis iii) Acute pain iv) Ankylosing Spondylitis | i) ADULTS: 200 mg once daily. May increase to 200 mg bid, if necessary. CHILD not recommended ii) 100mg twice daily, increased if necessary to 200 mg 2 times daily; CHILD not recommended iii) 400mg as a single dose on first day followed by 200mg once daily on subsequent days iv) Initial, 200 mg once daily or 100 mg twice daily; if no effect after 6 weeks, may increase to max. 400 mg daily in 1-2 divided doses. If no response following 2 weeks of treatment with 400 mg/day, consider discontinuation and alternative treatment | |
| 302 | Celecoxib 400 mg Capsule | M01AH01-000-C10-02-XXX | A* | i) Osteoarthritis ii) Rheumatoid Arthritis iii) Acute pain iv) Ankylosing Spondylitis | i) ADULTS: 200 mg once daily. CHILD not recommended ii) 100 mg twice daily, increased if necessary to 200 mg 2 times daily; CHILD not recommended iii) 400 mg as a single dose on first day followed by 200 mg once daily on subsequent days iv) Initial, 200 mg once daily or 100 mg twice daily; if no effect after 6 weeks, may increase to max. 400 mg daily in 1-2 divided doses. If no response following 2 weeks of treatment with 400 mg/day, consider discontinuation and alternative treatment | |
| 303 | Cephalexin Monohydrate 125 mg/5 ml Syrup | J01DB01-010-F21-01-XXX | B | Respiratory tract infections, ear, nose and throat infections, urinary tract infections, obstetric and gynaecologic infections | None | CHILD: 25 - 100 mg/kg/day every 6 hourly. Maximum: 4 g daily |
| 304 | Cephalexin Monohydrate 250 mg Capsule | J01DB01-010-C10-01-XXX | B | i) Respiratory tract infection, urinary tract infection ii) Complicated, recurrent or chronic infections, bronchitis iii) Pneumonia | None | i) 250 mg 6 hourly ii) 250 - 500 mg 6 hourly iii) 1 - 1.5 g 3 times daily or 4 times daily. Maximum: 6 g/day Child: 25-100 mg/kg daily in divided doses. Max: 4 g daily. |
| 305 | Cephalexin Monohydrate 250 mg Tablet | J01DB01-010-T10-01-XXX | B | i) Respiratory tract infection, urinary tract infection ii) Complicated, recurrent or chronic infections, bronchitis iii) Pneumonia | None | i) 250 mg 6 hourly ii) 250 - 500 mg 6 hourly iii) 1 - 1.5 g 3 times daily or 4 times daily. Maximum: 6 g/day Child: 25-100 mg/kg daily in divided doses. Max: 4 g daily. |
| 306 | Cephalexin Monohydrate 250 mg/5ml Syrup | J01DB01-010-F21-02-xxx | B | Respiratory tract infections, ear, nose and throat infections, urinary tract infections, obstetric and gynaecologic infections | None | CHILD: 25 - 100 mg/kg/day every 6 hourly. Maximum: 4 g daily |
| 307 | Cephalexin Monohydrate 500mg Capsule | J01DB01-010-C10-02-XXX | B | i) Respiratory tract infection, urinary tract infection ii) Complicated, recurrent or chronic infections, bronchitis iii) Pneumonia | None | i) 250 mg 6 hourly ii) 250 - 500 mg 6 hourly iii) 1 - 1.5 g 3 times daily or 4 times daily. Maximum: 6 g/day |
| 308 | Cephalexin Monohydrate 500mg Tablet | J01DB01-010-T10-02-XXX | B | i) Respiratory tract infection, urinary tract infection ii) Complicated, recurrent or chronic infections, bronchitis iii) Pneumonia | None | i) 250 mg 6 hourly ii) 250 - 500 mg 6 hourly iii) 1 - 1.5 g 3 times daily or 4 times daily. Maximum: 6 g/day Child: 25-100 mg/kg daily in divided doses. Max: 4 g daily. |
| 309 | Ceritinib 150mg Hard Capsules | L01XE28-000-C11-01-XXX | A* | Monotherapy, first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) | None | 450mg orally once daily with food until disease progression or unacceptable toxicity |
| 310 | Cetirizine HCl 10mg Tablet | R06AE07-110-T10-01-XXX | B | Urticaria, allergic dermatoses (insect bites, atopic eczema), perennial rhinitis, allergic rhinitis | ADULT and CHILD over 6 years:10 mg daily or 5 mg twice daily. Child 2-6 years: 5 mg once daily or 2.5 mg twice daily | |
| 311 | Cetrimide 1-2% Lotion. | D08AJ04000L6001XX | C+ | As shampoo and cleansing agent | Apply to affected area | |
| 312 | Cetrorelix 0.25mg Injection | H01CC02-122-P40-01-XXX | A* | Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques | None | Given by SC 0.25 mg/day, given either in the morning beginning on the day 5 or 6 of ovarian stimulation or in the evening beginning on day 5, and continued until ovulation induction |
| 313 | Cetuximab 5 mg/ml Solution for Infusion | L01XC06-000-P50-02-XXX | A* | For neo-adjuvant treatment of KRAS wild type metastatic colorectal cancer with the aim of liver resection. | To be prescribed in patients with the following conditions: i) The primary colorectal tumour has been resected or is potentially resected. ii)The metastatic disease is confined to the liver and is unresectable iii) Patient is fit enough to undergo surgery to resect the primary colorectal tumour and to undergo liver surgery if the metastases become resectable after treatment with cetuximab. - The treatment is limited to 16 weeks | Administered once a week. The very first dose is 400mg cetuximab per m2 body surface area with a recommended infusion period of 120 minutes. All subsequent weekly doses are 250mg per m2 body surface area each with a recommended infusion period of 60 minutes. The maximum infusion rate must not exceed 10mg/min. |
| 314 | Charcoal, Activated 250mg Tablet | A07BA01-000-T10-01-XXX | C | i) Diarrhoea and food poisoning; ii) Reduce absorption of drugs, plant, inorganic poison and chemicals in poisoning cases. | None | i) ADULT: 500mg -1000mg given 3-4 times daily. CHILD (up to 12 years): 250-500mg 3-4 times daily. ii) ADULT and CHILD over 12 years: initial 25-100 g or 1-2g/kg; repeat initial dose as soon as possible or 25-50 g every 4-6 hours. CHILD (up to 12 years): 0.5 to 1 g/kg/dose (Maximum: 50 g/dose). Dose may be repeated every 2-6 hours as needed. |
| 315 | Charcoal, Activated 50 g Granules | A07BA01-000-F10-01-XXX | A | Emergency treatment of acute oral poisoning and drug overdose | None | ADULT and CHILD 12 years and above: Acute poisoning: 50 to 100g in suspension. Severe poisoning: 50 to 100g as an initial dose followed by 20g every 4 to 6 hours. CHILD up to 12 years: 1 g/kg/dose (Maximum: 50 g/dose). Dose may be repeated every 4 to 6 hours as needed. Dosing is individualised and according to product insert/protocol. |
| 316 | Chlorambucil 2mg Tablet | L01AA02000T1001XX | A | Low grade lymphoma, chronic lymphocytic leukaemia. Ovarian cancer | None | General : Initial :0.1 -0.2 mg/kg body weight daily for 4 - 8 weeks maintenance : given either by reduced daily dosage or intermittent course of treatment. Chronic Lymphocytic Leukaemia: initial : 0.15mg/kg/day until total leukocyte count has fallen to 10,000peruL, then resumed treatment until 4 weeks after the end of the first course then continued at a dosage 0.1mg/kg/day. |
| 317 | Chloramphenicol 0.5% Eye Drops | S01AA01-000-D20-01-XXX | C | Ophthalmic infections | None | Instill 1 drop of a 0.5% solution every 2 hr. Increase dosage interval upon improvement. |
| 318 | Chloramphenicol 1% Eye Ointment | S01AA01-000-G51-01-XXX | C | Treatment of ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol susceptible organisms | None | ADULT and CHILD : Apply to the conjunctiva, a thin strip (approximately 1 cm) of ointment every 3 hours or more frequently |
| 319 | Chloramphenicol 250mg Capsule | J01BA01-126-C10-01-XXX | B | Treatment of typhoid, paratyphoid fevers, bronchopneumonia and enteric infection | None | ADULT: 500 mg 4 times daily or 50 mg/kg/day in 4 divided doses. Maximum dose: 4 g/day. CHILD: 25 - 100 mg/kg/day in 4 divided doses |
| 320 | Chloramphenicol 5% w/v Ear Drops | S02AA01-000-D10-01-XXX | C | Acute otitis media, otitis externa with perforation | None | Apply 2 - 3 drops into the ear 2 - 3 times daily. Not to be used for long term |
| 321 | Chloramphenicol Sodium Succinate 1 g Injection | J01BA01-520-P40-01-XXX | B | Treatment of typhoid, paratyphoid fevers, bronchopneumonia and enteric infection | None | Adult:50 to 100 mg/kg/day in 4 divided doses. Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50-100 mg/kg/day in 4 divided doses |
| 322 | Chlorhexidine 1:200 (0.5%) in Alcohol (Hand Disinfectant). | D08AC52-137-L99-01-XXX | C+ | Use as hand disinfectant for pre-surgical operation and skin disinfectant. | None | Pre-op surgical hand disinfection: Spread 5ml throughly over both hands and forearms, rubbing vigorously. When dry apply a further 5ml and repeat procedure. Antiseptic hand disinfection on the ward: Spread 3ml throughly over the hands and wrist rubbing vigorously until dry. Disinfection of patient's skin: Prior to surgery, apply to a sterile swab and rub thoroughly over the operation site for a minimum of 2 mins |
| 323 | Chlorhexidine Gluconate 0.2 % Mouthwash | R02AA05-137-M20-01-XXX | C | As a gargle | None | Rinse mouth with 10 ml for about 1 minute twice daily |
| 324 | Chlorhexidine Gluconate 1% cream | D08AC02-137-G10-01-XX | C+ | As a disinfectant cream. It can be used for disinfection or lubrication during gynaecological and obstetric procedures or childbirth. | None | Apply as required on affected area after cleaning |
| 325 | Chlorhexidine Gluconate 2% in Alcohol 70% Solution | D08AC52137L9902XX | C | Use as disinfectant in central venous catheter care bundle | Skin Preparation: Use Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70% and allow to dry. Catheter access: Apply to catheter ports or hubs prior to accessing the line for administering fluids or injections | |
| 326 | Chlorhexidine Gluconate 4% Scrub | D08AC02137M9901XX | C+ | Surgical hand scrub/disinfection, pre-op skin preparation | Surgical hand disinfection: Apply 5ml to clean hands and forearms for 1 min. Rinse and repeat with another 5ml for a further 2 mins and then rinse and dry. General skin disinfection: Apply appropriate quantity to wet area and scrub for 1 min. Rinse thoroughly & dry | |
| 327 | Chlorhexidine Gluconate 5% Solution | D08AC02-137-L99-01-XXX | C+ | Use as antiseptic and disinfectant in: i) Preoperative skin disinfection; ii) Emergency disinfection of instruments; iii) Wounds or burns. | None | To be used as diluted solution: (i) 0.5 % w/v Aqueous solution : Dilute 10 ml of solution with 70% alcohol up to 100ml. (ii) 0.5 % w/v Aqueous solution : Dilute 10 ml of solution with 70% alcohol up to 100ml. Immerse for 2 minutes (iii) 0.05 % w/v aqueous solution : Dilute 1 ml of solution with 100 ml of sterile water. |
| 328 | Chlorinated Lime Powder | V07AV00-000-F99-01-XXX | C | Antiseptic and disinfectants | None | Not applicable |
| 329 | Chlorinated Lime Solution & Buffered Acetate Solution | D08A000-999-G99-01-XXX | C | Use as skin disinfectant for wound and ulcer cleansing | None | Apply to affected areas undiluted as a cleansing agent |
| 330 | Chloroquine Phosphate 250 mg Tablet (150mg Chloroquine base) | P01BA01-162-T10-01-XXX | C | Treatment of malaria - acute attack | None | ADULT 600 mg base stat, 300 mg 6 - 8 hours later and a further 300 mg on each of 2 following days. CHILD 3 - 4 years : 150 mg base stat, 75 mg 6 hours later, then 75 mg daily for 2 days. CHILD 5 - 8 years : 300 mg stat, 150 mg 6 hours later, then 150 mg daily for 2 days |